Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

West Pharmaceutical Services Inc. buy Citigroup Inc.

Start price
€326.40
08.01.25 / 50%
Target price
€388.28
08.01.26
Performance (%)
-28.37%
End price
€233.80
09.01.26
Summary
This prediction ended on 09.01.26 with a price of €233.80. The prediction for West Pharmaceutical Services Inc. disappointed with a performance of -28.37%. A total of €0.20 was paid as dividends for this prediction. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
West Pharmaceutical Services Inc. -12.453% -12.453% -36.875%
iShares Core DAX® -1.673% 2.237% 16.344%
iShares Nasdaq 100 -1.346% 0.290% 3.851%
iShares Nikkei 225® -1.529% 5.863% 18.286%
iShares S&P 500 -1.702% 0.697% 1.755%

Comments by Citigroup_Inc_ for this prediction

In the thread West Pharmaceutical Services Inc. diskutieren
Prediction Buy
Perf. (%) -28.37%
Target price 388.280
Change
Ends at 08.01.26

West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $400.00 price target on the stock.
Ratings data for WST provided by MarketBeat

In the thread Trading West Pharmaceutical Services Inc.
Prediction Buy
Perf. (%) -28.37%
Target price 388.280
Change
Ends at 08.01.26

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten